ASH 2022 | sciencenewsnet.in

Breaking News

Amazon’s Return-to-Office Strategy: Expert Insights on Remote Work Challenges

Sunflower Bank Brings Back Beloved Model Train Display for the Holidays, Supporting Lighting Campus for Hope

World’s oldest lizard wins fossil fight

Wistar Institute Scientists Identify Important Factor in Neural Development

MSU experts: Breaking down the 2024 presidential and Michigan statewide election results

Worried about a pregnant woman’s stress and mental health? Her saliva may hold the key.

WCS calls for urgent action from US and Mexico to stop illegal cattle ranching fueling screwworm resurgence

Benchmarking CEBAF

Roboticist Hod Lipson Featured in New Bloomberg Docuseries

UM researchers using AI to improve cancer research and early detection of genetic diseases

27 Nov, 2024

Novel Drug Shows Early Promise in Treating Multiple Myeloma

December 11, 2022 sarah JonasResearch Results

A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma, a form of bone marrow cancer, in a study presented by researchers from the University of Pennsylvania’s Abramson Cancer Center at the 2022 American Society of Hematology (ASH) Annual Meeting (Abstract 565).